| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PROT.21942 |
| P698 | PubMed publication ID | 18214957 |
| P50 | author | Catharine Whiteside | Q113565363 |
| P2093 | author name string | Lakshmi P Kotra | |
| Lianhu Wei | |||
| Sishi Tang | |||
| Victor Xiao | |||
| P2860 | cites work | The Universal Protein Resource (UniProt) | Q24558582 |
| SWISS-MODEL: An automated protein homology-modeling server | Q24672647 | ||
| Basic local alignment search tool | Q25938991 | ||
| Regulation of protein kinase C zeta by PI 3-kinase and PDK-1 | Q28567633 | ||
| Protein kinase C: structure, function, and regulation | Q28618608 | ||
| The hydrophobic phosphorylation motif of conventional protein kinase C is regulated by autophosphorylation | Q28646394 | ||
| Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models | Q29616389 | ||
| Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer | Q33370385 | ||
| What are the dielectric "constants" of proteins and how to validate electrostatic models? | Q34325469 | ||
| Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif | Q34446130 | ||
| Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions | Q34466011 | ||
| Protein kinase C activation and the development of diabetic complications | Q34469779 | ||
| Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors | Q34626222 | ||
| Mesangial cell protein kinase C isozyme activation in the diabetic milieu | Q34629037 | ||
| Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm | Q35031770 | ||
| Selective protein kinase C inhibitors and their applications | Q35610642 | ||
| Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications | Q36256287 | ||
| Electrostatic interactions in the GCN4 leucine zipper: substantial contributions arise from intramolecular interactions enhanced on binding | Q36281595 | ||
| Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. | Q36590164 | ||
| Regulation of membrane trafficking and endocytosis by protein kinase C: emerging role of the pericentrion, a novel protein kinase C-dependent subset of recycling endosomes | Q36688504 | ||
| Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family; two distinct classes of PKC, conventional cPKC and novel nPKC. | Q37261630 | ||
| Electrostatic interactions in macromolecules: theory and applications | Q37938174 | ||
| Free energy via molecular simulation: applications to chemical and biomolecular systems | Q38648060 | ||
| Protein kinase Cdelta activation by interleukin-1beta stabilizes inducible nitric-oxide synthase mRNA in pancreatic beta-cells | Q40841049 | ||
| Protein kinase C isozymes and substrates | Q41099683 | ||
| Regulation of protein kinase C. | Q41382903 | ||
| (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta | Q42555309 | ||
| Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. | Q43678172 | ||
| Synthesis, in vitro pharmacology, and molecular modeling of syn-huprines as acetylcholinesterase inhibitors. | Q43821288 | ||
| Potential tumor-selective nitroimidazolylmethyluracil prodrug derivatives: inhibitors of the angiogenic enzyme thymidine phosphorylase. | Q44272700 | ||
| Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site? | Q44388134 | ||
| Staurosporine: a prototype of a novel class of inhibitors of tumor cell invasion? | Q44485095 | ||
| Catalytic domain crystal structure of protein kinase C-theta (PKCtheta). | Q45057148 | ||
| Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf. | Q45952403 | ||
| Calculation and prediction of binding free energies for the matrix metalloproteinases | Q46980158 | ||
| The intrinsic ATPase activity of protein kinase C is catalyzed at the active site of the enzyme | Q48466812 | ||
| Design of improved protein inhibitors of HIV-1 cell entry: Optimization of electrostatic interactions at the binding interface. | Q50762559 | ||
| A fast flexible docking method using an incremental construction algorithm. | Q52298930 | ||
| Parametrized Models of Aqueous Free Energies of Solvation Based on Pairwise Descreening of Solute Atomic Charges from a Dielectric Medium | Q57402396 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 447-460 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Proteins | Q7251514 |
| P1476 | title | Protein kinase C isozymes and their selectivity towards ruboxistaurin | |
| P478 | volume | 72 |
| Q27321219 | A small-molecule screen for enhanced homing of systemically infused cells |
| Q39349244 | Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy. |
| Q51732685 | Inhibition of protein kinase C in diabetic nephropathy--where do we stand? |
| Q37992101 | Protein kinase C βII in diabetic complications: survey of structural, biological and computational studies |
| Q30391488 | Structural Models for the Design of PKMzeta Inhibitors with Neurobiological Indications |
| Q37399929 | Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice |
Search more.